## **Core Concept**
DNA-dependent RNA synthesis, also known as transcription, is the process by which the information in a strand of DNA is copied into a new molecule of messenger RNA (mRNA). This process is crucial for gene expression and is catalyzed by the enzyme RNA polymerase. Inhibitors of this process can act by binding to RNA polymerase or by interacting with DNA or RNA, thereby preventing the transcription process.

## **Why the Correct Answer is Right**
The correct answer, , is a well-known inhibitor of bacterial RNA polymerase. It works by binding to the beta subunit of RNA polymerase, thereby inhibiting the initiation of RNA synthesis. This action is bactericidal and is specific to bacterial RNA polymerase, which is distinct from the RNA polymerase found in eukaryotic cells. This specificity makes it an effective antibiotic against bacterial infections.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option is incorrect because is not primarily known for inhibiting DNA-dependent RNA synthesis. Its mechanism of action is different and not directly related to the inhibition of RNA polymerase.
* **Option B:** - This option is incorrect because acts by inhibiting protein synthesis, not by inhibiting DNA-dependent RNA synthesis. It binds to the 30S subunit of the bacterial ribosome.
* **Option D:** - This option is incorrect because is an antiviral drug that works by inhibiting viral replication, not by directly inhibiting DNA-dependent RNA synthesis in bacteria or eukaryotes.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that is a critical drug in the treatment of tuberculosis and works by inhibiting RNA synthesis in Mycobacterium tuberculosis. It is a classic example of a drug that targets bacterial RNA polymerase.

## **Correct Answer:** . Rifampicin